Hepatitis Monthly

Published by: Kowsar

Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland

Marta Kucharska 1 , * , Malgorzata Inglot 1 , Aleksandra Szymczak 1 , Weronika Rymer 1 , Malgorzata Zalewska 1 , Krzysztof Malyszczak 2 , Urszula Zaleska-Dorobisz 3 and Malgorzata Kuliszkiewicz-Janus 4
Authors Information
1 Department of Infectious Diseases, Hepatology and Acquired Immune Deficiencies, Wroclaw Medical University, Wroclaw, Poland
2 Department of Psychiatry, Division of Psychotherapy and Psychosomatic Medicine, Wroclaw Medical University, Wroclaw, Poland
3 Department of General and Pediatric Radiology, Wroclaw Medical University, Wroclaw, Poland
4 Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
Article information
  • Hepatitis Monthly: September 01, 2016, 16 (9); e35658
  • Published Online: July 23, 2016
  • Article Type: Research Article
  • Received: December 22, 2015
  • Revised: June 12, 2016
  • Accepted: July 2, 2016
  • DOI: 10.5812/hepatmon.35658

To Cite: Kucharska M, Inglot M, Szymczak A, Rymer W, Zalewska M, et al. Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland, Hepat Mon. 2016 ;16(9):e35658. doi: 10.5812/hepatmon.35658.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut. 2000; 47(6): 845-51[PubMed]
  • 2. Windyga J, Grabarczyk P, Stefanska E, Buczma A, Szczepanik AB, Klukowska A, et al. [Prevalence of HCV, HBV and HIV infections among severe Polish haemophiliacs]. Przegl Epidemiol. 2008; 62(2): 415-23[PubMed]
  • 3. Barbosa AP, Martins RM, Teles SA, Silva SA, Oliveira JM, Yoshida CF. Prevalence of hepatitis C Virus infection among hemophiliacs in Central Brazil. Mem Inst Oswaldo Cruz. 2002; 97(5): 643-4[PubMed]
  • 4. Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood. 1993; 81(2): 412-8[PubMed]
  • 5. Maor Y, Bashari D, Kenet G, Lalezari S, Lubetsky A, Luboshitz J, et al. Hepatitis C at the israeli national hemophilia center. Haemophilia. 2006; 12(1): 68-74[DOI][PubMed]
  • 6. Al-Kubaisy WA, Al-Naib KT, Habib MA. Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad. East Mediterr Health J. 2006; 12(3-4): 264-9[PubMed]
  • 7. Wilde JT. HIV and HCV coinfection in haemophilia. Haemophilia. 2004; 10(1): 1-8
  • 8. Evatt BL. The tragic history of AIDS in the hemophilia population, 1982-1984. J Thromb Haemost. 2006; 4(11): 2295-301
  • 9. Grabarczyk P, Brojer E, Windyga J, lopaciuk S, Klukowska A, Mikulska M. [GBV-C/HGV and TTV infection markers in Polish blood donors and haemophilia patients]. Przegl Epidemiol. 2006; 60(3): 581-8[PubMed]
  • 10. Langar H, Triki H, Gouider E, Bahri O, Djebbi A, Sadraoui A, et al. [Blood-transmitted viral infections among haemophiliacs in Tunisia]. Transfus Clin Biol. 2005; 12(4): 301-5[DOI][PubMed]
  • 11. Franchini M, Mannucci PM. Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis. 2012; 7: 24[DOI][PubMed]
  • 12. Srivastava A, Brewer AK, Mauser‐Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013; 19(1)
  • 13. Windyga J, Lopaciuk S, Stefanska E, Juszynski A, Wozniak D, Strzelecki O, et al. Haemophilia in poland. Haemophilia. 2006; 12(1): 52-7
  • 14. White G2, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, et al. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001; 85(3): 560[PubMed]
  • 15. Magdzik WW. Hepatitis B epidemiology in Poland, Central and Eastern Europe and the newly independent states. Vaccine. 2000; 18 Suppl 1-6[PubMed]
  • 16. Flisiak R, Halota W, Horban A, Juszczyk J, Pawlowska M, Simon K. Prevalence and risk factors of HCV infection in Poland. Eur J Gastroenterol Hepatol. 2011; 23(12): 1213-7[DOI][PubMed]
  • 17. Godzik P, Kolakowska A, Madalinski K, Stepien M, Zielinski A, Goralewska A, et al. [Prevalence of anti-HCV antibodies among adults in Poland--results of cross-sectional study in general population]. Przegl Epidemiol. 2012; 66(4): 575-80[PubMed]
  • 18. Bielawski K, Wlasiuk M, Truskolawska M, Falkiewicz B. HCV infection in Poland. Arch Med Res. 2000; 31(5): 532-5
  • 19. Grabarczyk P, Kopacz A, Sulkowska E, Kubicka-Russel D, Mikulska M, Brojer E, et al. Blood donors screening for blood born viruses in Poland. Przegl Epidemiol. 2015; 69(3): 473-7[PubMed]
  • 20. Khan MM, Tait RC, Kerr R, Ludlam CA, Lowe GD, Murray W, et al. Hepatitis C infection and outcomes in the Scottish haemophilia population. Haemophilia. 2013; 19(6): 870-5[DOI][PubMed]
  • 21. Taherkhani R. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol. 2015; 21(38): 10790[DOI]
  • 22. Hough C, Lillicrap D. Gene therapy for hemophilia: an imperative to succeed. J Thromb Haemost. 2005; 3(6): 1195-205[DOI][PubMed]
  • 23. Alavian SM, Aalaei-Andabili SH. Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis. Hepat Mon. 2012; 12(4): 244-52[DOI][PubMed]
  • 24. Brojer E. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Poland. Vox Sang. 2005; 89(4): 267-8[DOI][PubMed]
  • 25. Grabarczyk P. Safety of blood in terms of virological tests. Acta Haematol Pol. 2013; 44: 3294-300
  • 26. Lee C, Dusheiko G. The natural history and antiviral treatment of hepatitis C in haemophilia. Haemophilia. 2002; 8(3): 322-9[PubMed]
  • 27. Simanis R, Lejniece S, Sochnevs A, Eglite J, Chernevska G, Kovalova Z, et al. Natural clearance of hepatitis C virus in hemophilia patients. Medicina (Kaunas). 2008; 44(1): 15-21[PubMed]
  • 28. Panasiuk A, Flisiak R, Mozer-Lisewska I, Adamek A, Tyczyno M, Halota W, et al. Distribution of HCV genotypes in Poland. Przegl Epidemiol. 2013; 67(1): 11-6[PubMed]
  • 29. Assarehzadegan MA, Ghafourian Boroujerdnia M, Zandian K. Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran. Iran Red Crescent Med J. 2012; 14(8): 470-4[PubMed]
  • 30. Zhubi B, Mekaj Y, Baruti Z, Bunjaku I, Belegu M. Transfusion-transmitted infections in haemophilia patients. Bosn J Basic Med Sci. 2009; 9(4): 271-7[PubMed]
  • 31. El-Faramawy AA, El-Rashidy OF, Tawfik PH, Hussein GH. Transfusion transmitted hepatitis: where do we stand now? A one center study in upper egypt. Hepat Mon. 2012; 12(4): 286-91[DOI][PubMed]
  • 32. Lok AS, McMahon BJ, Practice Guidelines Committee AAFTSOLD. Chronic hepatitis B. Hepatology. 2001; 34(6): 1225-41[DOI][PubMed]
  • 33. Sharma SK, Saini N, Chwla Y. Hepatitis B virus: inactive carriers. Virol J. 2005; 2(1): 1
  • 34. Bura M, Bura A, Adamek A, Michalak M, Marszalek A, Hryckiewicz K, et al. Seroprevalence of hepatitis A virus antibodies (anti-HAV) in adult inhabitants of Wielkopolska region, Poland--the role of simple demographic factors. Ann Agric Environ Med. 2012; 19(4): 738-41[PubMed]
  • 35. Pachnia D, Polz-Gruszka D, Macielag P, Polz-Dacewicz M. Prevalence of hepatitis A virus antibodies in Central-Eastern Poland–a comparative study (1990-2012). Curr Issues Pharm Med Sci. 2014; 27(1): 17-9
  • 36. Ryszkowska A, Gladysz A, Inglot M, Molin I. [Prevalence of anti-HAV antibodies in selected groups of children]. Przegl Epidemiol. 2000; 54(3-4): 375-83[PubMed]
  • 37. Pramoolsinsap C, Poovorawan Y, Hirsch P, Busagorn N, Attamasirikul K. Acute, hepatitis-A super-infection in HBV carriers, or chronic liver disease related to HBV or HCV. Ann Trop Med Parasitol. 1999; 93(7): 745-51[PubMed]
  • 38. Lee CA. The natural history of HIV disease in haemophilia. Blood Rev. 1998; 12(3): 135-44[PubMed]
  • 39. McVerry BA, Ross MG, Knowles WA, Voke J. Viral exposure and abnormal liver function in haemophilia. J Clin Pathol. 1979; 32(4): 377-81[PubMed]
  • 40. Enck RE, Betts RF, Brown MR, Miller G. Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases. Transfusion. 1979; 19(1): 32-8[PubMed]
  • 41. Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012; 3: 388[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments